Smith & Nephew SNATS, Inc. (NYSE:SNN) shares saw strong trading volume on Tuesday . 5,371,264 shares were traded during mid-day trading, an increase of 1,215% from the previous session’s volume of 408,525 shares.The stock last traded at $37.81 and had previously closed at $36.14.
Several equities analysts recently issued reports on the company. Zacks Investment Research lowered Smith & Nephew SNATS from a “buy” rating to a “hold” rating in a research report on Tuesday, September 19th. BidaskClub upgraded Smith & Nephew SNATS from a “buy” rating to a “strong-buy” rating in a research report on Friday, June 23rd. Five investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. Smith & Nephew SNATS presently has an average rating of “Hold” and a consensus target price of $41.00.
The stock has a market cap of $16.55 billion, a PE ratio of 19.25 and a beta of 0.74. The company’s 50 day moving average is $36.25 and its 200-day moving average is $34.62.
The company also recently disclosed a semiannual dividend, which will be paid on Wednesday, November 1st. Shareholders of record on Friday, October 6th will be paid a $0.246 dividend. The ex-dividend date of this dividend is Thursday, October 5th. This represents a yield of 1.37%.
A number of institutional investors have recently made changes to their positions in the business. Cambiar Investors LLC grew its stake in Smith & Nephew SNATS by 2.8% in the second quarter. Cambiar Investors LLC now owns 5,288,915 shares of the medical equipment provider’s stock valued at $184,319,000 after acquiring an additional 145,159 shares during the period. Arrowstreet Capital Limited Partnership grew its stake in Smith & Nephew SNATS by 13.8% in the second quarter. Arrowstreet Capital Limited Partnership now owns 2,986,759 shares of the medical equipment provider’s stock valued at $104,089,000 after acquiring an additional 362,484 shares during the period. Bank of America Corp DE grew its stake in Smith & Nephew SNATS by 10.9% in the first quarter. Bank of America Corp DE now owns 1,526,036 shares of the medical equipment provider’s stock valued at $47,200,000 after acquiring an additional 149,672 shares during the period. Renaissance Technologies LLC grew its stake in Smith & Nephew SNATS by 4.7% in the first quarter. Renaissance Technologies LLC now owns 734,000 shares of the medical equipment provider’s stock valued at $22,703,000 after acquiring an additional 32,750 shares during the period. Finally, Dalton Greiner Hartman Maher & Co. grew its stake in Smith & Nephew SNATS by 2,645.8% in the second quarter. Dalton Greiner Hartman Maher & Co. now owns 497,676 shares of the medical equipment provider’s stock valued at $17,344,000 after acquiring an additional 479,551 shares during the period. 6.37% of the stock is owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION WARNING: This piece of content was posted by Community Financial News and is the property of of Community Financial News. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://www.com-unik.info/2017/10/10/smith-nephew-snats-inc-snn-sees-strong-trading-volume.html.
Smith & Nephew SNATS Company Profile
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
What are top analysts saying about Smith & Nephew SNATS Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Smith & Nephew SNATS Inc. and related companies.